TransMedics Group Earnings Review: Q4 Summary
Benzinga Insights 8 months ago
Earnings
TransMedics Group (NASDAQ:TMDX) released its Q4 earnings on Tuesday, February 24, 2026 at 04:05 PM.
Here's what's important from the earnings announcement.
Earnings
TransMedics Group beat estimated earnings by 46.15%, reporting an EPS of $0.57 versus an estimate of $0.39.
Revenue was up $39.14 million from the same period last year.
Previous Earnings Records
The company beat on EPS by $0.3 in the previous quarter, leading to a 1.09% increase share price change the next day.
Here's a look at TransMedics Group's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.36 | 0.45 | 0.24 | 0.16 |
| EPS Actual | 0.66 | 0.92 | 0.70 | 0.19 |
| Revenue Estimate | 144.83M | 147.60M | 123.39M | 110.29M |
| Revenue Actual | 143.82M | 157.37M | 143.54M | 121.62M |
To track all earnings releases for TransMedics Group visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.